A population-based study of transdermal fentanyl initiation in Australian clinical practice
暂无分享,去创建一个
N. Gisev | B. Larance | L. Degenhardt | S. Pearson | S. Larney | B. Blanch
[1] T. Dobbins,et al. To what extent do data from pharmaceutical claims under‐estimate opioid analgesic utilisation in Australia? , 2018, Pharmacoepidemiology and drug safety.
[2] W. Hall,et al. Trends in heroin and pharmaceutical opioid overdose deaths in Australia. , 2017, Drug and alcohol dependence.
[3] R. Bruno,et al. A nationwide study of the extent and factors associated with fentanyl use in Australia , 2017, Research in social & administrative pharmacy : RSAP.
[4] S. Schug,et al. Fentanyl Formulations in the Management of Pain: An Update , 2017, Drugs.
[5] G. Guyatt,et al. Attitudes toward the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain: A qualitative study. , 2016, Journal of opioid management.
[6] T. Dobbins,et al. Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated. , 2016, British journal of clinical pharmacology.
[7] J. Gurwitz,et al. New Initiation of Long‐Acting Opioids in Long‐Stay Nursing Home Residents , 2016, Journal of the American Geriatrics Society.
[8] Madison,et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[9] Sallie-Anne Pearson,et al. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. , 2016, British journal of clinical pharmacology.
[10] D. Currow,et al. Using opioids in general practice for chronic non‐cancer pain: an overview of current evidence , 2016, The Medical journal of Australia.
[11] S. Bugden,et al. Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches , 2016, Canadian Medical Association Journal.
[12] J. Kahn,et al. Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence , 2016, Pain practice : the official journal of World Institute of Pain.
[13] R. Chou,et al. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.
[14] S. Pearson,et al. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers , 2015, BMC Research Notes.
[15] Lisa G. Pont,et al. Safety of opioid patch initiation in Australian residential aged care , 2015, The Medical journal of Australia.
[16] W. Hall,et al. The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain , 2015, Pain.
[17] N. Gisev,et al. The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia , 2015, BMJ Open.
[18] M. Kunz,et al. Pain management in patients with dementia , 2013, Clinical interventions in aging.
[19] E. Garbe,et al. Utilisation of transdermal fentanyl in Germany from 2004 to 2006 , 2012, Pharmacoepidemiology and Drug Safety.
[20] R. Sabatowski,et al. Utilisation of transdermal fentanyl in Germany from 2004–2006 by Edeltraut Garbe and colleagues , 2012, Pharmacoepidemiology and drug safety.
[21] E. Garbe,et al. Utilisation of transdermal fentanyl in Germany from 2004 to 2006 , 2012, Pharmacoepidemiology and drug safety.
[22] Christine Y. Lu,et al. Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. , 2011, Journal of clinical epidemiology.
[23] V. Mor,et al. Frequency of long-acting opioid analgesic initiation in opioid-naïve nursing home residents. , 2009, Journal of pain and symptom management.
[24] A. Dahan,et al. Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone) , 2008, Pain practice : the official journal of World Institute of Pain.
[25] P. Slattum,et al. Pharmacodynamics in older adults: a review. , 2007, The American journal of geriatric pharmacotherapy.
[26] R. Herings,et al. Utilisation pattern of fentanyl transdermal system in The Netherlands , 2005, Pharmacoepidemiology and drug safety.
[27] F. Blyth,et al. Chronic pain in Australia: a prevalence study , 2001, Pain.
[28] Julie Byles,et al. Health and Ageing , 2017 .
[29] S. Hyland,et al. Safety Issues with Fentanyl Patches Require Pharmaceutical Care , 2008 .